Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Leonardo G. Fonseca"'
Autor:
Leonardo G. Fonseca, Andre T.C. Chen, Irai S. de Oliveira, Aline L. Chagas, Jaime A.P. Kruger, Flair J. Carrilho
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
The incidence of hepatocellular carcinoma (HCC) is expected to increase in the coming years, and strategies to mitigate the burden of this disease are needed in different regions. Geographic variations in epidemiology and risk factors, such as viral
Externí odkaz:
https://doaj.org/article/4f0ee5c5e4ba42a291822703aa671c65
Autor:
José Maurício Mota, Mariana Scaranti, Leonardo G. Fonseca, Diego Araújo Tolói, Veridiana Pires de Camargo, Rodrigo Ramella Munhoz, Olavo Feher, Paulo M. Hoff
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 2, Pp 481-487 (2016)
Background: Kaposiform hemangioendothelioma (KHE) is a rare neoplasm of vascular origin that typically arises from the skin or soft tissues as a solitary tumor. The optimal therapy for this disease is still unknown. We report the case of an adult pat
Externí odkaz:
https://doaj.org/article/bbbc2ee66d974d43a184900ee285dfe7
Autor:
Romualdo Barroso-Sousa, Rodrigo R. Munhoz, Milena P. Mak, Leonardo G. Fonseca, Angelo B. S. Fede, Rudinei Diogo Marques Linck, Clovis R. Coelho, Camila M. V. Moniz, Ciro E. Souza, Carlos Dzik
Publikováno v:
International Brazilian Journal of Urology, Vol 40, Iss 6, Pp 835-841 (2014)
Purpose To assess the activity, safety and treatment patterns of sunitinib in patients with poor-risk metastatic renal cell carcinoma (mRCC). Materials and Methods We retrospectively reviewed the charts of poor risk patients treated with sunitinib fr
Externí odkaz:
https://doaj.org/article/375918afa0b04176931af29148506301
Autor:
Leonardo G Fonseca, Lucas Fernando Uratani, Gabriella Fernandes Soares, Paulo Siqueira Amaral, Regiane Saraiva Souza Melo Alencar, Aline Lopes Chagas, Venancio Avancini Ferreira Alves, Flair Jose Carrilho
Publikováno v:
Molecular and Clinical Oncology. 18
Background: The search for prognostic markers in hepatocellular carcinoma (HCC) is essential for clinical decisions. In addition to established variables such as liver function and tumor extent, cancer-associated inflammation can impact clinical outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::499ea9c7f3a7d40b5a53324f2b3fd8d6
https://doi.org/10.3892/mco.2023.2625
https://doi.org/10.3892/mco.2023.2625